Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.6M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
52.3M
-
Shares change
-
+1.89M
-
Total reported value, excl. options
-
$1.14B
-
Value change
-
+$54.3M
-
Put/Call ratio
-
0.14
-
Number of buys
-
65
-
Number of sells
-
-51
-
Price
-
$21.89
Significant Holders of Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) as of Q4 2021
154 filings reported holding SNDX - Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share as of Q4 2021.
Syndax Pharmaceuticals Inc - Common Stock, par value $0.0001 per share (SNDX) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 52.3M shares
of 86.6M outstanding shares and own 60.38% of the company stock.
Largest 10 shareholders include Avidity Partners Management LP (4.82M shares), BlackRock Inc. (3.69M shares), Nantahala Capital Management, LLC (2.85M shares), FRAZIER MANAGEMENT LLC (2.77M shares), STATE STREET CORP (2.48M shares), VANGUARD GROUP INC (2.34M shares), Avoro Capital Advisors LLC (2.18M shares), PFM Health Sciences, LP (2.1M shares), BVF INC/IL (2.1M shares), and CITADEL ADVISORS LLC (2.02M shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.